Background The aim of this study was to investigate the anti-proliferative effect of Lycopene on HGC-27 cells.
Introduction
Lycopene is the most abundant carotenoid found in ripe tomatoes and tomato based products and is responsible for their bright red color (Hobson & Davies, 1971) . Several health benefits have been correlated with the dietary intake of tomatoes (Giovannucci, 1999 ; Rao, S. Agarwal, 1999; Bramley, 2000) . Lycopene in tomatoes may contribute to prevent against cardiovascular diseases (Willcox et al, 2003) and different types of cancer due to its strong antioxidant activity (Di Mascio et al, 1989; Conn et al, 1991) .
Gastric cancer is the second most common malignancy worldwide. The etiology of gastric cancer is multifactorial and predominantly dietary. High intake of smoked and salted foods is a major risk factor associated with the etiology of gastric cancer (Xu et al, 2013 , Bi et al, 2016 Ren et al, 2016 , Bartsch et al, 1992 . In addition, exposure to preformed N-nitroso compounds in the diet is a crucial contributory factor in the development of gastric cancer (Zhao et al, 2016) . Therefore, development of an effective therapeutic method without side effects is an urgent need. There is increased evidence for an association between high consumption of fruits and vegetables and reduced risk of gastric cancer, suggesting that diet-derived agents offer protection against gastric cancer (Fahmy et al, 2015) . As shown in Fig. 3 , Western blot analysis showed that after the treatment of lycopene, no obvious change in the expression levels of LC3-II was observed, whereas the levels of LC3-I increased. After the treatment of HCQ, obvious increase in the expression levels of LC3-II wasn't observed. The levels of LC3-I increased. As shown in Fig. 4 , after the treatment of lycopene, no obvious change in the expression levels of ERK was observed, whereas the levels of p-ERK dose-dependently and significantly increased.
Experimental results showed no significant changes in body weight, diet consumption, and water drinking (data not shown) in both experimental and control animals. Moreover, we did not find any adverse effects in terms of general behavior of the animals treated with lycopene and 5-Fu, as compared with the control animals throughout the experiment. Regarding the anticancer efficacy of lycopene, all mice inoculated with HGC-27 cells started growing tumours of 2 mm 3 after 3 weeks of treatment, and reduced tumor volumes or weight were observed in groups receiving 20, 40, 60 mg/kg lycopene treatment in 30 days ( Fig. 5 and 6 ). 
Discussion
In the present study, we evaluate the antitumour effect of lycopene on HGC-27. We found that lycopene dose-dependently and time-dependently inhibited HGC-27 cells growth. This showed that lycopene had strong antitumour activity.
Recent study has shown that several molecules required for autophagy also regulate apoptosis (Yousefi et al, 2006) . For example, an apoptotic function has been reported for microtubule-associated protein light chain 3 (LC3), which has a well-defined function in autophagy (Kar et al, 2009; Huang et al, 2013) . In addition, a number of cancers overexpress LC3 (Yoshioka et al, 2008 ).
In the present study, selected doses of lycopene didn't significantly increase LC3-II protein expression in HGC-27 cells. This indicated that lycopene induced HGC-27 cells dealth via other pathways.
ERK is one of the sub-pathways of MAPK signaling (Zhang & Liu, 2002) proteins that are activated by transient and reversible phosphorylation at key amino acid residues. MAPKs are important regulators of cell proliferation. MEK (Scholl et al, 2005 ) is the same as MAPKs and can activate ERK. ERK is one of key proteins that function as checkpoints in cellular mitosis.
Activation of ERK has been reported to enhance cell differentiation, growth or cell apopto-sis. Furthermore, cell culture showed that ERK protein was activated by several growth factors with stimulating activity of mitosis. ERK regulates cellular entry into S phase from G1 phase. It was reported that a negative mutant of the ERK sub-pathway element genes, or antibodies to the proteins, In the present study, selected doses of lycopene significantly increased p-ERK proteins expression in HGC-27 cells. These findings explained that lycopene may cause HGC-27 cells dealth by upregulating p-ERK proteins expression.
In the present study, results showed no significant changes in body weight, diet consumption, and water drinking (data not shown) in both experimental and control animals. All mice fed with lycopene affected growing tumors of 2 mm 3 after 30 days of treatment, and reduced tumor volumes were observed in groups receiving lycopene treatment in 30 days.
Conclusion
This study demonstrated that lycopene inhibits HGC-27 cells growth via the ERK signaling. In addition, lycopene significantly decreased tumour size in nude mice. Lycopene may serve as an anti-tumour strategy for gastric cancer diseases.
